Antibiotics Business Drives Lukang Pharma's Profitability Boost
This article was originally published in PharmAsia News
Executive Summary
Lukang Pharmaceutical recently reported first quarter profits of RMB 47.27 million, up 855 percent, due mostly to substantial growth in its antibiotics business